Peregrine Ventures

Peregrine Ventures, Israel's leading venture capital fund for early stage investments, is focused on investing in promising early stage High-tech companies with a strong emphasis in the Life Sciences, Telecommunications, Information Technology, Cleantech & Energy.

Collaborating with talented entrepreneurs, Peregrine has earned a solid reputation for cultivating innovation technologies into lucrative companies with significant global presence. more..

Testimonials
Portfolio Companies
Recent News
Mar. 17, 2010
NLT, Peregrine's Portfolio Company, Raised $8.8M

Mar. 15, 2010
Industry at Crisis: Bibi, Help the High Tech Industry (Hebrew Text)

Jan. 14, 2010
OticPharma completes Phase II ear infection treatment trial (English Text)

Jan. 14, 2010
OticPharma completes Phase II ear infection treatment trial (Hebrew Text)

May. 6, 2009
Apexum receives FDA 510(k) clearance to market its Apexum Ablator device

Mar. 30, 2009
Globes - Incentive - Peregrine's Technological Incubator, won Best Incubator Award for 2008 (Hebrew Text)

Mar. 25, 2009
Incentive - Peregrine's Technological Incubator awarded Best Incubator of 2008 and Valtech Cardio Ltd. (a Peregrine portfolio company) awarded Best Company of 2008

Mar. 1, 2009
Apexum’s article was selected to feature on the cover page of the February 2009 issue of the Journal of Endodontics

 

CNBC: Israel - Leader of Business Innovation
CNBC interview with Dan Senor,
co-author of "Start-up Nation: The Story of Israel's Economic Miracle"
© Peregrine Ventures  |  Terms & Conditions  |  Privacy Policy Created by Volle'